🔎 Trials Near Me

Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › California › Los Angeles

Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma Los Angeles, CA keessatti

Qorannoo 17 Diffuse Large B-Cell Lymphoma f Los Angeles fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Namoota walitti qabaa jiraSadarkaa 2
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06500273

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Cedars-Sinai Medical Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06649812

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • David Geffen School of Medicine at UCLA, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06091865

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07226843

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Children's Hospital Los Angeles ( Site 1006), Los Angeles
6 Months – 25 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06395103

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Namoota walitti qabaa jiraSadarkaa 2
  • Valkyrie Clinical Trials, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06806033

A Study of ARC-02 in B-cell NHL

Namoota walitti qabaa jiraSadarkaa 1
  • Start Cala, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles (UCLA) Medical Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Cedars-Sinai Medical Center, Los Angeles
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT05887167

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Valkyrie Clinical Trials, Los Angeles
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles (UCLA), Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • START Los Angele, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07424833

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
Umuriin 12 hanga 95 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04329728

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT05256641

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Namoota walitti qabaa jiraSadarkaa 2
  • Cedars Sinai Medical Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Onk-2025 · NCT05890352

A Study of NX-1607 in Adults With Advanced Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • University of Southern California, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT05107674

Qorannoo Diffuse Large B-Cell Lymphoma magaalota biroo keessatti

Qorannoo biroo Los Angeles keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.